Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

Recruiting

Phase 2

CannabidiolCannabidiol as a Treatment for Social Anxiety Disorder (R61)

Sponsor:

NYU Langone Health

Code:

NCT05571592

Conditions

Social Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

Cannabidiol

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2025-05-06.